Sara Tabtabai, MD
she/her/hers
Assistant ProfessorCards
About
Research
Publications
2026
Pregnancy-related Heart Failure Readmissions in the US: Analysis of the Nationwide Readmissions Database
Senior author. In review - The Journal of the American Heart AssociationPeer-Reviewed Original ResearchLower Risk of Cardiovascular Events in Patients with Heart Failure Initiated on Semaglutide 2.4 mg in the Real-world: Results from the SCORE-HF Study
Senior author. In Review - JCF Intersections.Peer-Reviewed Original Research
2025
The Effect of a Best Practice Advisory on the Utilization and Impact of Palliative Care Consultation in Heart Failure Hospitalizations
Gooding K, Naraparaju V, Esstman B, Wakefield D, Evjen M, Naseer A, Tabtabai S. The Effect of a Best Practice Advisory on the Utilization and Impact of Palliative Care Consultation in Heart Failure Hospitalizations. Palliative Medicine Reports 2025, 6: pmr.2024.0106. PMID: 40308711, PMCID: PMC12040558, DOI: 10.1089/pmr.2024.0106.Peer-Reviewed Original ResearchPalliative care consultationPalliative care consultation groupLength of stayCare consultationAcute decompensated heart failureImpact of palliative care consultationReadmission ratesBest practice advisoryGoals of carePractice alertMedian length of stayClinician biasPractice advisoryAdmitted PatientsElectronic recordsWhite patientsAcute decompensated heart failure admissionsDecompensated heart failureLow ejection fractionHeart failure hospitalizationRe-HospitalizationAdmissionReadmissionConsultationEjection fractionElectronic health record nudges to optimize guideline-directed medical therapy for heart failure
Fuery M, Clark K, Sikand N, Tabtabai S, Sen S, Wilson F, Desai N, Ahmad T, Samsky M. Electronic health record nudges to optimize guideline-directed medical therapy for heart failure. Heart Failure Reviews 2025, 30: 771-776. PMID: 40106122, DOI: 10.1007/s10741-025-10503-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsElectronic health recordsClinical decision supportGuideline-directed medical therapyPotential of electronic health recordsElectronic health record systemsDiverse healthcare settingsGDMT adherenceCare qualityClinician workflowHealth recordsAlert contentHF careHealthcare settingsPatient careInformed treatment decisionsTargeted alertingQuality gapEnhanced usabilityImprove heart failureHeart failureDecision supportReal-timeCareTreatment decisionsAlerting strategy
2024
Cardiovascular Care in the United States Penny Wise and Pound Foolish
Ahmad T, Desai N, Tabtabai S. Cardiovascular Care in the United States Penny Wise and Pound Foolish. Journal Of The American College Of Cardiology 2024, 84: 694-695. PMID: 39142722, DOI: 10.1016/j.jacc.2024.07.001.Commentaries, Editorials and Letters
2023
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities
Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.Peer-Reviewed Original ResearchPredictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis
Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.Peer-Reviewed Original ResearchConceptsElixhauser co-morbidity indexHeart failureMultivariate logistic regressionCo-morbiditiesSecondary diagnosisPatients admitted with HFPatient co-morbiditiesAdmitted with HFDetrimental to patientsPopulation of patientsLogistic regressionCo-morbidity indexReadmission riskDiagnosis of HFSecondary diagnosis of HFNationwide Readmissions DatabaseCo-morbid complicationsRenal failureComparing PatientsShort-term rehospitalizationHF patientsStatistically significant predictorsPredicting 30-day readmissionIncreased riskElixhauser co-morbiditiesEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA: The Journal Of The American Medical Association 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2019
Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge
Sharma T, Tigadi S, Baldwin J, Tabtabai S. Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge. American Journal Of Case Reports 2019, 20: 252-257. PMID: 30804319, PMCID: PMC6402271, DOI: 10.12659/ajcr.912169.Peer-Reviewed Original ResearchConceptsErythrocyte sedimentation rateEjection fractionApical ballooningPR depressionHistory of emotional stressElevated erythrocyte sedimentation rateNon-obstructive coronary diseaseNon-obstructive coronary arteriesDiagnosis of myopericarditisPleuritic chest painVentricular apical ballooningReduced ejection fractionT-wave inversionType of therapyFlu-like illnessSecondary to extensionNext 2 daysMasquerading presentationPleuritic painViral prodromeAcute myopericarditisChest painAtypical presentationMyocardial inflammationElectrocardiogram findings
2018
Updates in heart failure 30-day readmission prevention
Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHospital Readmissions Reduction ProgramAffordable Care ActReduce health care costsReadmission ratesReduce short-term readmissionsReadmissions Reduction ProgramHF readmissionHealth care costsCare costsShort-term readmissionCare ActAdmission diagnosisPrevent heart failureReduction programsRemote hemodynamic monitoringReadmissionMedical therapyHeart failureHF patientsHemodynamic monitoringHospitalProgram
Academic Achievements & Community Involvement
Teaching & Mentoring
Mentoring
Marah Maayah, MD
Internal medicine resident2026 - PresentEman Mubarak
Internal medical resident2025 - PresentMaha Inam
Internal medical resident2025 - PresentEmma Barry
Yale Internal medical resident2024 - Present
Clinical Care
Overview
Sara Tabtabai, MD, is a cardiologist who specializes in heart failure and cardiovascular medicine. She diagnoses and treats conditions related to advanced heart failure, women's heart disease, cardio-obstetrics, and amyloid cardiomyopathy (where abnormal proteins accumulate in the heart muscle, leading to damage and impaired heart function).
As an assistant professor at Yale School of Medicine, Dr. Tabtabai is involved in research aimed at enhancing the understanding and treatment of heart failure.
Dr. Tabtabai earned her medical degree at the University of Connecticut School of Medicine. She then completed residency and fellowship training in internal and cardiovascular medicine, as well as advanced training in heart failure and transplantation, at Massachusetts General Hospital.
Clinical Specialties
Cardiovascular Medicine; Heart Failure
Fact Sheets
Cardiac Amyloidosis
Learn More on Yale MedicineAmyloidosis
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale MedicineHeart Transplant
Learn More on Yale Medicine
Board Certifications
Obesity Medicine
- Certification Organization
- AB of Obesity Medicine
- Original Certification Date
- 2025
Yale Medicine News
News
News
- May 13, 2026
Women As One Mentorship Awards Presented to Tabtabai and Alaiwi
- March 18, 2026
Advancing Research and Care To Improve Maternal Heart Health
- November 18, 2025
Upcoming Conference: Obesity and Genetic Heart Disease in the Era of Preventive Cardiology
- January 08, 2025
Sara Tabtabai Elected Governor of the Connecticut Chapter of the American College of Cardiology
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.